aid: akston-biosciences name: Akston Biosciences description: 'Akston Biosciences Corporation is a privately held biotechnology company headquartered in Beverly, Massachusetts, founded in 2011 by the team from SmartCells, Inc. and led by CEO Todd Zion, Ph.D. Akston designs, develops and manufactures protein therapeutics built on its proprietary Ambifect Fc-fusion protein platform, with a pipeline focused on companion-animal (veterinary) medicine: PD-L1 monoclonal antibody oncology candidates (AKS-701d, AKS-619d), a long-acting GLP-1 for feline weight management (AKS-562c), an IL-31 targeting therapy for canine pruritus (AKS-699), and NGF-targeting candidates for osteoarthritis pain. Its veterinary insulin program was sold to Dechra in 2024, and human programs continue through the Vakston and Diamune Therapeutics subsidiaries. The company announced a manufacturing expansion in Shreveport, Louisiana. Akston is a therapeutics developer and manufacturer, not a software vendor: it publishes a corporate marketing site and no public API, SDK, developer portal or machine-readable specification.' url: https://raw.githubusercontent.com/api-evangelist/akston-biosciences/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: stub x-tier-reason: harvest image: https://www.akstonbio.com/wp-content/themes/ssw-akston/assets/images/header/akston-logo.svg specificationVersion: '0.23' created: '2026-08-06' modified: '2026-08-06' tags: - Company - Biotechnology - Life Sciences - Pharmaceuticals - Animal Health - Veterinary Medicine - Protein Therapeutics - Biomanufacturing apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://www.akstonbio.com/ - type: About url: https://www.akstonbio.com/about/ - type: Blog url: https://www.akstonbio.com/news/ - type: BlogRSS url: https://www.akstonbio.com/feed/ - type: Contact url: https://www.akstonbio.com/contact/ - type: Careers url: https://www.akstonbio.com/careers/ - type: Team url: https://www.akstonbio.com/team/ - type: Partners url: https://www.akstonbio.com/partners/ - type: LinkedIn url: https://www.linkedin.com/company/akston-biosciences-corporation/ - type: DomainSecurity url: security/akston-biosciences-domain-security.yml x-enrichment: date: '2026-08-06' status: minimal artifacts_added: 1 pass: local-v1 x-coverage: state: none reason: not-a-software-company detail: Akston Biosciences is a veterinary protein-therapeutics developer and manufacturer whose entire web presence is a nine-page WordPress marketing site (about/process/pipeline/news/careers/contact) with no developer section; api., developer., docs. and portal.akstonbio.com are all NXDOMAIN and every spec and .well-known probe returned 404. evidence: - url: https://www.akstonbio.com/openapi.json status: 404 - url: https://www.akstonbio.com/llms.txt status: 404 - url: https://www.akstonbio.com/.well-known/agent-card.json status: 404 - url: https://www.akstonbio.com/.well-known/security.txt status: 404 - url: https://www.akstonbio.com/sitemap.xml status: 200 checked: '2026-08-06'